Thornberry Nancy sold DNLI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001797826-26-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 2, 2026

Published

Sep 4, 2026

Ingested by INSIDER

Nov 5, 02:18 UTC

Last re-read

Nov 5, 02:18 UTC

Extracted facts

Filer

Thornberry Nancy

Role

Director

Transaction

Open-market saleAs filed: “S”

Asset

Denali Therapeutics Inc.

Ticker

DNLI

Shares

615

Price per share

$23.74

Value

$14,600

Execution date (reported)

Sep 2, 2026

Owned after transaction

19.7K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

2

Calculation

What this establishes

Thornberry Nancy filed this Form 4 reporting a open-market sale of DNLI on Sep 2, 2026. It became public on Sep 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Thornberry Nancycik:0001797826

Issuer

Denali Therapeutics Inc.cik:0001714899

Revision history · 0

No field has changed since this record was first ingested.